The Department of Veterans Affairs announced it would fund research into psychedelic therapies for the first time in over 50 years, driven by the urgency of veterans suffering from PTSD.
While initial anecdotal reports claim ibogaine may help some individuals with PTSD, its effectiveness remains unproven, and the drug carries serious risks, including cardiotoxicity and other fatal side effects.
Collection
[
|
...
]